Daniel Portsmouth
Vaccine R&D
Vienna, Austria
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.
Journal: Journal of virology
Published: November 25, 2015
An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial.
Journal: Clinical and vaccine immunology : CVI
Published: December 26, 2014
Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.
Journal: Clinical and vaccine immunology : CVI
Published: October 31, 2014
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
Journal: Clinical and vaccine immunology : CVI
Published: September 05, 2014
Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients.
Journal: Open forum infectious diseases
Published: June 19, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.
Journal: Clinical and vaccine immunology : CVI
Published: April 18, 2014
Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice.
Journal: Virology journal
Published: January 24, 2014
Lyme disease vaccination: safety first - authors' reply.
Journal: The Lancet. Infectious diseases
Published: December 21, 2013
A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studies.
Journal: Expert review of vaccines
Published: September 24, 2013
Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.
Journal: The Journal of infectious diseases
Published: September 18, 2013
Last Updated: 09/26/2026